$CLRI
Cleartronic, Inc. Stock $clri

$clri Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-K Financial Statement

#000109181823000200 Filed on December 21, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2023
Revenue	$606.0K	$554.3K	$2.132M
YoY Change	19.62%	13.2%	5.67%
Cost Of Revenue	$95.63K	$86.42K	$316.2K
YoY Change	23.41%	0.42%	-5.38%
Gross Profit	$510.4K	$467.8K	$1.816M
YoY Change	18.93%	15.92%	7.86%
Gross Profit Margin	84.22%	84.41%	85.17%
Selling, General & Admin	$526.2K	$509.7K	$1.729M
YoY Change	35.03%	86.98%	54.26%
% of Gross Profit	103.1%	108.94%	95.25%
Research & Development	$13.56K	$1.500K	$27.31K
YoY Change	-37.85%	-97.57%	-86.67%
% of Gross Profit	2.66%	0.32%	1.5%
Depreciation & Amortization	$0.00	$1.360K	$5.051K
YoY Change	-100.0%	36.0%	35.34%
% of Gross Profit	0.0%	0.29%	0.28%
Operating Expenses	$541.1K	$512.5K	$1.762M
YoY Change	31.15%	52.86%	32.49%
Operating Profit	-$30.73K	-$44.67K	$53.95K
YoY Change	-285.87%	-165.4%	-84.74%
Interest Expense	$4.350K	$690.00	$2.610K
YoY Change	690.91%	-630.77%	-592.45%
% of Operating Profit			4.84%
Other Income/Expense, Net	$48.40K		$2.607K
YoY Change	8716.03%		-94.48%
Pretax Income	$17.67K	-$43.98K	$56.56K
YoY Change	3.41%	-164.52%	-85.89%
Income Tax		$0.00	$0.00
% Of Pretax Income			0.0%
Net Earnings	$17.67K	-$54.32K	$56.56K
YoY Change	3.41%	-193.93%	-85.89%
Net Earnings / Revenue	2.92%	-9.8%	2.65%
Basic Earnings Per Share	$0.00		$0.00
Diluted Earnings Per Share	$0.00	$0.00	$0.00
COMMON SHARES
Basic Shares Outstanding	229.2M shares	228.9M shares	228.8M shares
Diluted Shares Outstanding	599.5M shares		599.1M shares

Balance Sheet

Concept	2023 Q4	2023 Q3	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$818.5K	$517.0K	$517.0K
YoY Change	192.18%	10.42%	10.42%
Cash & Equivalents	$818.5K	$517.0K
Short-Term Investments
Other Short-Term Assets	$85.58K	$68.52K	$68.52K
YoY Change	95.97%	27.81%	27.81%
Inventory	$27.65K	$21.91K	$21.91K
Prepaid Expenses	$85.58K	$30.27K
Receivables	$476.6K	$545.6K	$545.6K
Other Receivables	$56.72K	$2.730K	$2.730K
Total Short-Term Assets	$1.465M	$1.156M	$1.156M
YoY Change	61.28%	6.92%	6.92%
LONG-TERM ASSETS
Property, Plant & Equipment	$15.17K	$16.53K	$46.44K
YoY Change	7.87%	9.14%	206.74%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$160.5K	$144.1K	$144.1K
YoY Change	138.25%	110.56%	110.56%
TOTAL ASSETS
Total Short-Term Assets	$1.465M	$1.156M	$1.156M
Total Long-Term Assets	$160.5K	$144.1K	$144.1K
Total Assets	$1.626M	$1.300M	$1.300M
YoY Change	66.6%	13.09%	13.09%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$49.54K	$85.86K	$85.86K
YoY Change	-54.19%	14.15%	14.15%
Accrued Expenses	$25.27K	$24.58K	$24.58K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.534M	$1.216M	$1.216M
YoY Change	68.54%	11.83%	11.83%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$68.22K	$78.61K	$78.61K
YoY Change	-31.49%	-30.62%	-30.62%
Total Long-Term Liabilities	$68.22K	$78.61K	$78.61K
YoY Change	-31.49%	-30.62%	-30.62%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.534M	$1.216M	$1.216M
Total Long-Term Liabilities	$68.22K	$78.61K	$78.61K
Total Liabilities	$1.603M	$1.295M	$1.295M
YoY Change	58.68%	7.82%	7.82%
SHAREHOLDERS EQUITY
Retained Earnings	-$15.22M	-$15.24M
YoY Change	-0.37%	-0.37%
Common Stock	$2.291K	$2.291K
YoY Change	0.13%	0.44%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$22.84K	$5.177K	$5.180K
YoY Change
Total Liabilities & Shareholders Equity	$1.626M	$1.300M	$1.300M
YoY Change	66.6%	13.09%	13.09%

Cashflow Statement

Concept	2023 Q4	2023 Q3	2023
OPERATING ACTIVITIES
Net Income	$17.67K	-$54.32K	$56.56K
YoY Change	3.41%	-193.93%	-85.89%
Depreciation, Depletion And Amortization	$0.00	$1.360K	$5.051K
YoY Change	-100.0%	36.0%	35.34%
Cash From Operating Activities	$378.6K	$134.8K	$99.60K
YoY Change	-301.36%	-44.64%	33.42%
INVESTING ACTIVITIES
Capital Expenditures	$77.02K	$44.37K	$6.434K
YoY Change		-1933.47%	-14.02%
Acquisitions
YoY Change
Other Investing Activities		$0.00	$0.00
YoY Change
Cash From Investing Activities	-$77.02K	-$44.37K	-$50.81K
YoY Change		1733.47%	578.98%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		0.000
YoY Change
NET CHANGE
Cash From Operating Activities	$378.6K	134.8K	$99.60K
Cash From Investing Activities	-$77.02K	-44.37K	-$50.81K
Cash From Financing Activities		0.000
Net Change In Cash	$301.6K	90.46K	$48.79K
YoY Change	-260.4%	-62.48%	-27.36%
FREE CASH FLOW
Cash From Operating Activities	$378.6K	$134.8K	$99.60K
Capital Expenditures	$77.02K	$44.37K	$6.434K
Free Cash Flow	$301.6K	$90.46K	$93.16K
YoY Change	-260.4%	-63.22%	38.7%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001362516
CY2022Q3	clri	Interest Receivable Related Party Current InterestReceivableRelatedPartyCurrent		usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet		usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset		usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent		usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2023	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement		usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense		usd
CY2023	clri	Gain On Settlementand Reversal Of Accounts Payable GainOnSettlementandReversalOfAccountsPayable		usd
CY2023	us-gaap	Increase Decrease In Notes Receivable Related Parties Current IncreaseDecreaseInNotesReceivableRelatedPartiesCurrent		usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability		usd
CY2022	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets		usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
CY2023	clri	Cancellation Of458300 Shares Of Common Stock CancellationOf458300SharesOfCommonStock		usd
CY2022	clri	Cancellationof Shares Of Common Stock CancellationofSharesOfCommonStock		usd
CY2022	clri	Operating Lease Right Of Use Asset Recorded On Adoption Of Asc842 OperatingLeaseRightOfUseAssetRecordedOnAdoptionOfAsc842		usd
CY2022	clri	Share Cancellation ShareCancellation		usd
CY2023	clri	Series C Convertible Preferred Shares Exchanged For Common Stock SeriesCConvertiblePreferredSharesExchangedForCommonStock		usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset		usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability		usd
CY2022Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent		pure
CY2022	clri	Amorization On Rightofuse Opeating Lease Asset AmorizationOnRightofuseOpeatingLeaseAsset		usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments		usd
CY2022	us-gaap	Lease Cost LeaseCost		usd
CY2022	us-gaap	Operating Lease Payments Use OperatingLeasePaymentsUse		usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross		usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet		usd
CY2023Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	000-55329
CY2023	dei	Entity Registrant Name EntityRegistrantName	CLEARTRONIC, INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	FL
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	65-0958798
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	28050 S Highway 19 N
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Ste 310
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Clearwater
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33761
CY2023	dei	City Area Code CityAreaCode	(813)
CY2023	dei	Local Phone Number LocalPhoneNumber	289-7620
CY2023	dei	Security12b Title Security12bTitle	Common stock, par value $0.00001 per share
CY2023	dei	Trading Symbol TradingSymbol	CLRI
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023Q3	dei	Entity Public Float EntityPublicFloat	6439416	usd
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	229160695	shares
CY2023	dei	Auditor Firm AuditorFirmId	5036
CY2023	dei	Auditor Name AuditorName	Assurance Dimensions
CY2023	dei	Auditor Location AuditorLocation	Margate, Florida
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	516955	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	468167	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	63665	usd
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	18000	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	545573	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	538030	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	21913	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	21097	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	68522	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	53611	usd
CY2023Q3	clri	Interest Receivable Related Party Current InterestReceivableRelatedPartyCurrent	2724	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	1155687	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	1080905	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	16526	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	15142	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	44373	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	29914	usd
CY2023Q3	clri	Due From Related Party DueFromRelatedParty	53302	usd
CY2022Q3	clri	Due From Related Party DueFromRelatedParty	53302	usd
CY2023Q3	us-gaap	Other Assets OtherAssets	53302	usd
CY2022Q3	us-gaap	Other Assets OtherAssets	53302	usd
CY2023Q3	us-gaap	Assets Assets	1299802	usd
CY2022Q3	us-gaap	Assets Assets	1149349	usd
CY2023Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	85858	usd
CY2022Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	75217	usd
CY2023Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1105580	usd
CY2022Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1012211	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	24580	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	1216018	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	1087428	usd
CY2023Q3	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	72100	usd
CY2022Q3	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	113300	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6507	usd
CY2023Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	78607	usd
CY2022Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	113300	usd
CY2023Q3	us-gaap	Liabilities Liabilities	1294625	usd
CY2022Q3	us-gaap	Liabilities Liabilities	1200728	usd
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	5000000000	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	229160695	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	2291	usd
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	2281	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	15240104	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	15240112	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-15237292	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-15293848	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	5177	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-51379	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1299802	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1149349	usd
CY2023	us-gaap	Revenues Revenues	2131955	usd
CY2022	us-gaap	Revenues Revenues	2017563	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	316163	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	334138	usd
CY2023	us-gaap	Gross Profit GrossProfit	1815792	usd
CY2022	us-gaap	Gross Profit GrossProfit	1683425	usd
CY2023	us-gaap	Selling Expense SellingExpense	425498	usd
CY2022	us-gaap	Selling Expense SellingExpense	272521	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1303980	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1033796	usd
CY2023	us-gaap	Depreciation Depreciation	5051	usd
CY2022	us-gaap	Depreciation Depreciation	3732	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	27314	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	19742	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	1761843	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	1329791	usd
CY2022	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	47792	usd
CY2023	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	2607	usd
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-531	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2607	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	47261	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	56556	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	400895	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Profit Loss ProfitLoss	56556	usd
CY2022	us-gaap	Profit Loss ProfitLoss	400895	usd
CY2023	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	41038	usd
CY2022	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	41037	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	15518	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	359858	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	228786339	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	228239979	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	599107974	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	599601614	shares
CY2023	us-gaap	Net Income Loss NetIncomeLoss	56556	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	400895	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	5051	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3732	usd
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	17949	usd
CY2022	clri	Gain On Settlementand Reversal Of Accounts Payable GainOnSettlementandReversalOfAccountsPayable	47792	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	97994	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	14000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	105537	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	231785	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	816	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	6444	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	17635	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	6228	usd
CY2022	us-gaap	Increase Decrease In Notes Receivable Related Parties Current IncreaseDecreaseInNotesReceivableRelatedPartiesCurrent	8501	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	10640	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-36943	usd
CY2023	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	52169	usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-6285	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-16776	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	99595	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	74649	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6434	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7483	usd
CY2023	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	44373	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-50808	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-7483	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	48788	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	67166	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	468167	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	401001	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	516955	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	468167	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	117	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	53	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	400	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	690	usd
CY2023	clri	Number Of Common Stock Cancelled NumberOfCommonStockCancelled	458300	shares
CY2022	clri	Cancellation Of458300 Shares Of Common Stock CancellationOf458300SharesOfCommonStock	5	usd
CY2023	clri	Cancellationof Shares Of Common Stock CancellationofSharesOfCommonStock	10	usd
CY2023	clri	Operating Lease Right Of Use Asset Recorded On Adoption Of Asc842 OperatingLeaseRightOfUseAssetRecordedOnAdoptionOfAsc842	47863	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	-452274	usd
CY2022	us-gaap	Profit Loss ProfitLoss	400895	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-51379	usd
CY2023	us-gaap	Profit Loss ProfitLoss	56556	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	5177	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84E_eus-gaap--UseOfEstimates_zYF8IsSK2eDl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_860_zdqIrxPbJaC2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>USE OF ESTIMATES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In preparing the consolidated financial statements, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the balance sheet and operations for the reporting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although these estimates are based on managements knowledge of current events and actions it may undertake in the future, they may ultimately differ from actual results.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant estimates include the assumptions used in valuation of deferred tax assets, estimated useful life of property and equipment, valuation of inventory and allowance for credit losses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	41037	usd
CY2023	us-gaap	Profit Loss ProfitLoss	56556	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	63665	usd
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	18000	usd
CY2023Q3	us-gaap	Other Deferred Costs Net OtherDeferredCostsNet	38250	usd
CY2022Q3	us-gaap	Other Deferred Costs Net OtherDeferredCostsNet	38250	usd
CY2023Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	30272	usd
CY2022Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	15361	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	44373	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	usd
CY2022	us-gaap	Profit Loss ProfitLoss	400895	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	228786339	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	228239979	shares
CY2023	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	370321635	shares
CY2022	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	371361635	shares
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84E_eus-gaap--ConcentrationRiskCreditRisk_zky4pGTqLy23" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_864_ztuhTP0Hwfz8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONCENTRATION OF CREDIT RISK</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company currently maintains cash balances at one FDIC-insured banking institution. Deposits held in non interest-bearing transaction accounts are insured up to a maximum of $<span id="xdx_904_eus-gaap--CashFDICInsuredAmount_c20230930_pp0p0">250,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at all FDIC-insured institutions. As of September 30, 2023 and September 30, 2022, the Company had $<span id="xdx_90B_ecustom--AmountOfFdicInsuranceLimits_c20221001__20230930_pp0p0">118,140 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_909_ecustom--AmountOfFdicInsuranceLimits_c20211001__20220930_pp0p0">208,135</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, respectively, in excess of FDIC insurance limits.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q3	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023	clri	Amount Of Fdic Insurance Limits AmountOfFdicInsuranceLimits	118140	usd
CY2022	clri	Amount Of Fdic Insurance Limits AmountOfFdicInsuranceLimits	208135	usd
CY2023	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	27314	usd
CY2022	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	19742	usd
CY2023Q3	us-gaap	Deferred Revenue DeferredRevenue	1177680	usd
CY2022Q3	us-gaap	Deferred Revenue DeferredRevenue	1125511	usd
CY2023	us-gaap	Regulated Operating Revenue RegulatedOperatingRevenue	2131955	usd
CY2022	us-gaap	Regulated Operating Revenue RegulatedOperatingRevenue	2017563	usd
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	599107974	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	599601614	shares
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1125511	usd
CY2021Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1131796	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	2184124	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	2011278	usd
CY2023	us-gaap	Contract With Customer Asset Allowance For Credit Loss Writeoff ContractWithCustomerAssetAllowanceForCreditLossWriteoff	2131955	usd
CY2022	us-gaap	Contract With Customer Asset Allowance For Credit Loss Writeoff ContractWithCustomerAssetAllowanceForCreditLossWriteoff	2017563	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1177680	usd
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1125511	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	15518	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	359858	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	228786339	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	228239979	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	15518	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	359858	usd
CY2023	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	41038	usd
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2023Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	21913	usd
CY2022Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	21097	usd
CY2023	us-gaap	Advertising Expense AdvertisingExpense	95373	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	51318	usd
CY2023Q1	us-gaap	Area Of Land AreaOfLand	1145	sqft
CY2023	us-gaap	Payments For Rent PaymentsForRent	2134	usd
CY2023	us-gaap	Increase Decrease In Prepaid Rent IncreaseDecreaseInPrepaidRent	2198	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	29914	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	31087	usd
CY2023Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y3M
CY2023Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.08	pure
CY2023	clri	Amorization On Rightofuse Opeating Lease Asset AmorizationOnRightofuseOpeatingLeaseAsset	17949	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	2429	usd
CY2023	us-gaap	Lease Cost LeaseCost	20378	usd
CY2023	us-gaap	Operating Lease Payments Use OperatingLeasePaymentsUse	19206	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	47863	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	26184	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	6594	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	32778	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1691	usd
CY2023Q3	clri	Present Value Of Operating Lease Liability PresentValueOfOperatingLeaseLiability	31087	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	24580	usd
CY2023Q3	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	6507	usd
CY2023Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	28040	usd
CY2022Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	21605	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	11514	usd
CY2022Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6463	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	16526	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	15142	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	44373	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	44373	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5051	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3732	usd
CY2023Q3	us-gaap	Cumulative Dividends CumulativeDividends	205658	usd
CY2022Q3	us-gaap	Cumulative Dividends CumulativeDividends	165144	usd
CY2023	clri	Number Of Common Stock Shares Issued From Conversion Of Series C Preferred Stock Converted NumberOfCommonStockSharesIssuedFromConversionOfSeriesCPreferredStockConverted	1040000	shares
CY2022	clri	Cancellation Of Shares CancellationOfShares	458300	shares
CY2023	clri	Rent Expense RentExpense	22722	usd
CY2022	clri	Rent Expense RentExpense	26973	usd
CY2023	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	36000	usd
CY2022	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	39000	usd
CY2022Q4	clri	Advanced Amounts AdvancedAmounts	53302	usd
CY2022Q4	clri	Area Of Leased Facility AreaOfLeasedFacility	1145	sqft
CY2022Q4	clri	Monthly Rental Cost MonthlyRentalCost	2134	usd
CY2022Q4	clri	Monthly Rent MonthlyRent	2198	usd
CY2021Q4	clri	Area Of Leased Facility AreaOfLeasedFacility	2000	sqft
CY2021Q4	clri	Monthly Rental Cost MonthlyRentalCost	2200	usd
CY2021Q4	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2022-11-30
CY2023	us-gaap	Royalty Expense RoyaltyExpense	6000	usd
CY2022	us-gaap	Royalty Expense RoyaltyExpense	8000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	1750	usd
CY2022Q3	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	2842	usd
CY2023Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	40717	usd
CY2022Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	15880	usd
CY2023Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	3449013	usd
CY2022Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	3493201	usd
CY2023Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	3491480	usd
CY2022Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	3511923	usd
CY2023Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3491480	usd
CY2022Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3511923	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	11224	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	79558	usd
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	3111	usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	22049	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	26586	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	850	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	3267	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	2100	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-44188	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-104557	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0435	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0435	pure
CY2023	clri	Effective Rate Of Deferred Tax Asset EffectiveRateOfDeferredTaxAsset	0.2535	pure
CY2022	clri	Effective Rate Of Deferred Tax Asset EffectiveRateOfDeferredTaxAsset	0.2535	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.2535	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.2535	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0000	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0000	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	1	pure

Files In Submission

Name	View Source	Status
0001091818-23-000200-index-headers.html	Edgar Link	pending
0001091818-23-000200-index.html	Edgar Link	pending
0001091818-23-000200.txt	Edgar Link	pending
0001091818-23-000200-xbrl.zip	Edgar Link	pending
clri-20230930.xsd	Edgar Link	pending
clri1218202310k.htm	Edgar Link	pending
ex311.htm	Edgar Link	pending
ex312.htm	Edgar Link	pending
clri-20230930_cal.xml	Edgar Link	unprocessable
clri-20230930_lab.xml	Edgar Link	unprocessable
clri-20230930_def.xml	Edgar Link	unprocessable
clri-20230930_pre.xml	Edgar Link	unprocessable
clri1218202310k_htm.xml	Edgar Link	completed
ex321.htm	Edgar Link	pending
ex322.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CLRI
Cleartronic, Inc. Stock $clri

2023 Q4 Form 10-K Financial Statement

#000109181823000200 Filed on December 21, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CLRI Cleartronic, Inc. Stock $clri

2023 Q4 Form 10-K Financial Statement

#000109181823000200 Filed on December 21, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CLRI
Cleartronic, Inc. Stock $clri